Literature DB >> 21911510

Khat chewing in persons with severe mental illness in Ethiopia: a qualitative study exploring perspectives of patients and caregivers.

Solomon Teferra1, Charlotte Hanlon, Atalay Alem, Lars Jacobsson, Teshome Shibre.   

Abstract

People with severe mental illness (SMI) in Ethiopia chew khat despite advice from their physicians to desist. We wanted to better understand their reasons for khat chewing, including any benefits that they might gain. A qualitative study was conducted involving patients with SMI and their caregivers in Butajira. Reasons given by patients as well as caregivers were more or less congruent: social pressure, a means for survival by improving function, combating medication side effects, to experience pleasure and curbing appetite. These findings will be of value to health workers, caregivers and policymakers alike in improving care and understanding for this patient group. Furthermore, our study indicates a role for future research to explore potentially beneficial effects of khat in this population.

Entities:  

Mesh:

Year:  2011        PMID: 21911510     DOI: 10.1177/1363461511408494

Source DB:  PubMed          Journal:  Transcult Psychiatry        ISSN: 1363-4615


  10 in total

1.  Functional impairment among people with severe and enduring mental disorder in rural Ethiopia: a cross-sectional study.

Authors:  Kassahun Habtamu; Atalay Alem; Girmay Medhin; Abebaw Fekadu; Charlotte Hanlon
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2018-06-14       Impact factor: 4.328

2.  Chewing over the future: khat consumption, anxiety, depression, and time among young men in Jimma, Ethiopia.

Authors:  Daniel Mains; Craig Hadley; Fasil Tessema
Journal:  Cult Med Psychiatry       Date:  2013-03

3.  Khat use in people living with HIV: a facility-based cross-sectional survey from South West Ethiopia.

Authors:  Matiwos Soboka; Markos Tesfaye; Garumma Tolu Feyissa; Charlotte Hanlon
Journal:  BMC Psychiatry       Date:  2015-04-03       Impact factor: 3.630

4.  Tobacco dependence among people with mental illness: a facility-based cross sectional study from Southwest Ethiopia.

Authors:  Zemenay Molla; Lamesa Dube; Wolfgang Krahl; Matiwos Soboka
Journal:  BMC Res Notes       Date:  2017-07-17

5.  "I cry every day and night, I have my son tied in chains": physical restraint of people with schizophrenia in community settings in Ethiopia.

Authors:  Laura Asher; Abebaw Fekadu; Solomon Teferra; Mary De Silva; Soumitra Pathare; Charlotte Hanlon
Journal:  Global Health       Date:  2017-07-11       Impact factor: 4.185

6.  An assessment of khat consumption habit and its linkage to household economies and work culture: The case of Harar city.

Authors:  Zerihun Girma Gudata; Logan Cochrane; Gutema Imana
Journal:  PLoS One       Date:  2019-11-05       Impact factor: 3.240

7.  Mood Symptoms, Suicide, and Associated Factors Among Jimma Community. A Cross-Sectional Study.

Authors:  Yonas Tesfaye; Liyew Agenagnew; Susan Anand; Gudina Terefe Tucho; Zewdie Birhanu; Gutema Ahmed; Masrie Getnet; Kiddus Yitbarek
Journal:  Front Psychiatry       Date:  2021-03-19       Impact factor: 4.157

8.  Perspectives on reasons for non-adherence to medication in persons with schizophrenia in Ethiopia: a qualitative study of patients, caregivers and health workers.

Authors:  Solomon Teferra; Charlotte Hanlon; Teferra Beyero; Lars Jacobsson; Teshome Shibre
Journal:  BMC Psychiatry       Date:  2013-06-17       Impact factor: 3.630

9.  Magnitude and predictors of khat use among patients with tuberculosis in Southwest Ethiopia: A longitudinal study.

Authors:  Matiwos Soboka; Omega Tolessa; Markos Tesfaye; Kristina Adorjan; Wolfgang Krahl; Elias Tesfaye; Yimenu Yitayih; Ralf Strobl; Eva Grill
Journal:  PLoS One       Date:  2020-07-30       Impact factor: 3.240

10.  A systematic review on risk factors for khat chewing among adolescents in the African continent and Arabian Peninsula.

Authors:  Osman Abubakar Fiidow; Halimatus Sakdiah Minhat; Nor Afiah Mohd Zulkefli; Norliza Ahmad
Journal:  PLoS One       Date:  2022-02-03       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.